GLP1R and aspiration pneumonitis: Our query revealed one study with equal incidence of reported aspiration pneumonia in both the GLP-1 RA and placebo groups (clinicaltrials.gov ID NCT01147250); six studies had higher rates of aspiration and/or aspiration pneumonia in GLP-1 RA group compared to placebo/control (clinicaltrials.gov IDs NCT04184622, NCT03574597, NCT01720446, NCT01144338, NCT02692716, and NCT01621178); and two studies had higher incidences of reported aspiration and/or foreign body aspiration in the placebo group compared to the GLP-1 RA group.